PTEN and cancer: 34 We therefore chose to assess PTEN expression by IHC as one potential regulator of cancer progression in grade 7 disease. Loss of PTEN expression at the protein level was observed in 51% of our cohort when assessed by immunohistochemistry (Figure 2).